U.S.-China tariffs will have a $226M to $340M net impact on its bottom line in 2025, even after substantial mitigation efforts, the imaging manufacturer estimates.
Cardiologists are turning to leadless pacemakers more and more for cardiac pacing, but those devices have not previously been able to perform LBBAP. This new analysis includes new data on the world’s very first leadless LBBAP procedures.
“Dr. Swan is an inspiring and untiring leader who has served with distinction in his multiple ACR and professional roles," CEO Dana Smetherman, MD, said Monday.
An international team of researchers is calling on healthcare AI proponents to be more mindful of the technology’s unsuitability across much of the developing world.